Cure My Disease

Don't miss your cure!

 Log in / Sign up

New imaging device snaps detailed photos of annoying eye floaters

NCT ID NCT06204848

Knowledge-focused Sponsor: PulseMedica Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study tested a non-invasive imaging device that combines two eye-scanning technologies to capture detailed pictures of eye floaters in 44 adults. The goal was to build a database of images to help researchers learn more about floaters. Participants simply had their eyes scanned with the device, and no treatment was given.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this imaging database could help researchers better understand eye floaters and potentially improve future treatments.
What could go wrong
This was a small, completed data-collection study, not a treatment trial. The device is still investigational, and the findings may not lead to direct patient benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

44 people

The number who actually took part.

Started

Nov 2024

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 years or older * Symptomatic vitreous opacities (floaters) in vision * Clear ocular media, to allow a clear view of the vitreous for the SVO-ID Exclusion Criteria: * Younger than 18 years of age * Presence of vitreous hemorrhage * Cataract Grade 3 and above * Opacification of lens, cornea, or vitreous * Diagnosis of narrow angle glaucoma * Refractive error is outside the range of -6D to+3D * Astigmatism is outside the range of +/-2D of cylinder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Floaters are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vitreous floaters

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Floaters Vitreous opacities

Contacts and locations

Locations

  • Alberta Retina Consultants

    Edmonton, Alberta, T5H 0X5, Canada